2024 Q3 Form 10-Q Financial Statement

#000196504024000054 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $674.9M $662.4M
YoY Change -13.07% -16.47%
Cost Of Revenue $526.6M $525.3M
YoY Change -18.65% -19.11%
Gross Profit $148.3M $137.1M
YoY Change 14.87% -4.53%
Gross Profit Margin 21.97% 20.7%
Selling, General & Admin $136.3M $156.2M
YoY Change 72.75% 93.32%
% of Gross Profit 91.91% 113.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $21.20M $21.40M
YoY Change -13.82% -14.74%
% of Gross Profit 14.3% 15.61%
Operating Expenses $136.3M $156.2M
YoY Change 31.69% 93.32%
Operating Profit -$18.00M -$50.90M
YoY Change -228.57% -250.59%
Interest Expense -$22.40M -$45.20M
YoY Change -36.9% -6557.14%
% of Operating Profit
Other Income/Expense, Net $4.800M $9.000M
YoY Change 33.33% 2150.0%
Pretax Income -$35.80M -$88.60M
YoY Change 100.0% -327.76%
Income Tax -$17.30M $10.70M
% Of Pretax Income
Net Earnings -$27.90M -$138.4M
YoY Change 112.98% -589.05%
Net Earnings / Revenue -4.13% -20.89%
Basic Earnings Per Share -$0.31 -$1.55
Diluted Earnings Per Share -$0.31 -$1.55
COMMON SHARES
Basic Shares Outstanding 89.60M shares 89.40M shares
Diluted Shares Outstanding 89.60M shares 89.40M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $105.3M $126.2M
YoY Change -2.05% 10.41%
Cash & Equivalents $105.3M $126.2M
Short-Term Investments
Other Short-Term Assets $142.5M $123.6M
YoY Change 38.08% 20.59%
Inventory
Prepaid Expenses
Receivables $689.1M $637.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $936.9M $887.7M
YoY Change -25.51% -27.92%
LONG-TERM ASSETS
Property, Plant & Equipment $173.1M $173.1M
YoY Change -21.03% -18.46%
Goodwill $1.767B $1.726B
YoY Change -11.42% -14.79%
Intangibles $691.2M $691.9M
YoY Change -13.67%
Long-Term Investments
YoY Change
Other Assets $92.30M $83.80M
YoY Change 29.45% 0.12%
Total Long-Term Assets $2.727B $2.678B
YoY Change -10.86% -14.31%
TOTAL ASSETS
Total Short-Term Assets $936.9M $887.7M
Total Long-Term Assets $2.727B $2.678B
Total Assets $3.664B $3.565B
YoY Change -15.13% -18.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $137.6M $144.2M
YoY Change 7.25% 36.94%
Accrued Expenses $323.1M $343.3M
YoY Change -9.09% 2.11%
Deferred Revenue $321.1M $248.0M
YoY Change 21.26% -6.17%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $795.8M $749.0M
YoY Change 2.74% -0.41%
LONG-TERM LIABILITIES
Long-Term Debt $1.125B $1.124B
YoY Change -28.49% -28.82%
Other Long-Term Liabilities $37.60M $29.60M
YoY Change -63.74% -20.0%
Total Long-Term Liabilities $1.162B $1.153B
YoY Change -26.09% -28.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $795.8M $749.0M
Total Long-Term Liabilities $1.162B $1.153B
Total Liabilities $2.150B $2.104B
YoY Change -18.01% -19.22%
SHAREHOLDERS EQUITY
Retained Earnings -$335.8M -$307.9M
YoY Change 2463.36%
Common Stock $100.0K $100.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.514B $1.461B
YoY Change
Total Liabilities & Shareholders Equity $3.664B $3.565B
YoY Change -15.13% -18.15%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$27.90M -$138.4M
YoY Change 112.98% -589.05%
Depreciation, Depletion And Amortization $21.20M $21.40M
YoY Change -13.82% -14.74%
Cash From Operating Activities -$2.400M $273.7M
YoY Change -400.0% 81.5%
INVESTING ACTIVITIES
Capital Expenditures $8.200M $11.20M
YoY Change 60.78% 16.67%
Acquisitions
YoY Change
Other Investing Activities $100.0K $276.6M
YoY Change -98.72% 92100.0%
Cash From Investing Activities -$8.100M $265.4M
YoY Change -400.0% -2953.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.00M -504.0M
YoY Change 81.82% 243.79%
NET CHANGE
Cash From Operating Activities -2.400M 273.7M
Cash From Investing Activities -8.100M 265.4M
Cash From Financing Activities -14.00M -504.0M
Net Change In Cash -24.50M 35.10M
YoY Change 483.33% -788.24%
FREE CASH FLOW
Cash From Operating Activities -$2.400M $273.7M
Capital Expenditures $8.200M $11.20M
Free Cash Flow -$10.60M $262.5M
YoY Change 146.51% 85.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
30800000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
32000000.0 usd
us-gaap Net Income Loss
NetIncomeLoss
43300000 usd
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
568700000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1079500000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1110200000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97800000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
276300000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
693500000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1412800000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
31600000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
51100000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
214600000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23400000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
43300000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
44300000 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
3600000 usd
us-gaap Restructuring Costs
RestructuringCosts
13700000 usd
us-gaap Restructuring Costs
RestructuringCosts
4200000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1373300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-88300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
45700000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-700000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-79500000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-600000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5200000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6800000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
500000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10300000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000.0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36600000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-164300000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46100000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13100000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
25000000.0 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-179100000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
33000000.0 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5800000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-60300000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
10300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-239400000 usd
us-gaap Net Income Loss
NetIncomeLoss
43300000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.28
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.37
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.68
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.12
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.28
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.37
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.68
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
30800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-239400000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
29900000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-35400000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
49000000.0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
-2100000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
0 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
-2100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
2500000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
32000000.0 usd
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-32900000 usd
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
51100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
600000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-33500000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
62800000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-272900000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
94400000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1714100000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-101000000.0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26100000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15100000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10400000 usd
CY2024Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-200000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1591900000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-138400000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7400000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15000000.0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1461100000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3340000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12500000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
19100000 usd
CY2023Q1 ftre Net Transfers From To Parent Excluding Special Payment
NetTransfersFromToParentExcludingSpecialPayment
31200000 usd
CY2023Q2 ftre Net Transfers To Parent Special Payment
NetTransfersToParentSpecialPayment
1595000000 usd
CY2023Q2 ftre Net Transfers From To Parent Excluding Special Payment
NetTransfersFromToParentExcludingSpecialPayment
-122900000 usd
CY2023Q2 ftre Adjustments To Additional Paid In Capital Former Parent Investment Reclassification
AdjustmentsToAdditionalPaidInCapitalFormerParentInvestmentReclassification
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1747800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-239400000 usd
us-gaap Net Income Loss
NetIncomeLoss
43300000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44900000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
30100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16100000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
11900000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14300000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
24000000.0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11600000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4500000 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-23200000 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
12200000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7800000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6500000 usd
ftre Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
-359400000 usd
ftre Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
-11400000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11700000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17200000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13000000.0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19900000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
34200000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5500000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-34300000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
15200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
248100000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
148100000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
20500000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
25800000 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
276600000 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
100000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
300000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
256200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25500000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
474500000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
474500000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1061400000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
570000000.0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
26400000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
482700000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
ftre Special Payment To Former Parent
SpecialPaymentToFormerParent
0 usd
ftre Special Payment To Former Parent
SpecialPaymentToFormerParent
1595000000 usd
ftre Proceeds From Payments To Former Parent Company
ProceedsFromPaymentsToFormerParentCompany
0 usd
ftre Proceeds From Payments To Former Parent Company
ProceedsFromPaymentsToFormerParentCompany
-135400000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-482700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-125400000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000000.0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1300000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17600000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1500000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110400000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126200000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108900000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
ftre Number Of Countries With Primary Office Locations
NumberOfCountriesWithPrimaryOfficeLocations
5 country
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of June 30, 2024, one customer accounted for 15.4% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2023, two pharmaceutical companies accounted for approximately 17.0% and 11.2% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months ended June 30, 2024, one customer accounted for approximately 13.2% of revenues, and for the six months ended June 30, 2024, two customers accounted for approximately 13.6% and 11.3% of revenues. For the three months ended June 30, 2023, one customer accounted for 10.2% of revenues, and for the six months ended June 30, 2023, one customer accounted for 10.1% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain previously reported amounts have been reclassified to conform to the current year presentation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2024, a change in basis of presentation, to include information technology costs and certain facility costs in Selling, general and administrative expenses was made to improve comparability of costs against peer companies in the clinical research industry. As a result, the Company reclassified $33.1 and $78.3 from Direct costs, exclusive of depreciation and amortization, to Selling, general and administrative expenses, exclusive of depreciation and amortization in the condensed consolidated and combined statement of operations for the three and six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, relating to information technology costs and certain facility charges. There is no impact on total operating expenses, operating income or net income during the period ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June 30, 2023. Direct costs include payroll and related benefits for project-related employees, pass through costs,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> facility costs related to phase I clinics and other direct costs from the Transition Services Agreement with Labcorp. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, information technology costs, other facility charges, advertising and promotional expenses, administrative travel and credit loss provisions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company reclassified $0.1 from Other, net to Interest expense in the condensed consolidated and combined statement of operations for the six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
100000 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
24000000.0 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
662400000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
725100000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1324500000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1419000000 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
21900000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
17800000 usd
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
88200000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
420200000 usd
CY2024Q2 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
582400000 usd
CY2023Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
600000000.0 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32700000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31700000 usd
CY2024Q2 ftre Accounts Receivable And Contract With Customer Asset After Allowance For Credit Loss Current
AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent
637900000 usd
CY2023Q4 ftre Accounts Receivable And Contract With Customer Asset After Allowance For Credit Loss Current
AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent
988500000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
248000000.0 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
214200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
125500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
139400000 usd
CY2024Q2 us-gaap Accounts Receivable Sale
AccountsReceivableSale
300000000.0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31700000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12500000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
11500000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32700000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4357000000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.28
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
18000000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
52000000 usd
CY2023Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
22000000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
33000000 usd
CY2023Q2 ftre Accounts Receivable Purchase Program Maximum Facility Amount
AccountsReceivablePurchaseProgramMaximumFacilityAmount
80000000.0 usd
CY2023Q2 us-gaap Accounts Receivable Sale
AccountsReceivableSale
17500000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Receivables
ProceedsFromSaleOfOtherReceivables
17300000 usd
CY2024Q2 ftre Accounts Receivable Factored
AccountsReceivableFactored
0 usd
CY2024Q2 ftre Receivable Securitization Term
ReceivableSecuritizationTerm
P3Y
CY2024Q2 us-gaap Accounts Receivable From Securitization
AccountsReceivableFromSecuritization
300000000.0 usd
CY2024Q2 us-gaap Accounts Receivable Sale
AccountsReceivableSale
300000000.0 usd
CY2024Q2 us-gaap Proceeds From Sale Of Other Receivables
ProceedsFromSaleOfOtherReceivables
297900000 usd
CY2024Q2 ftre Accounts Receivable From Securitization Sale Fees
AccountsReceivableFromSecuritizationSaleFees
2100000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
4300000 usd
us-gaap Restructuring Charges
RestructuringCharges
13300000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-3000000.0 usd
ftre Restructuring Reserve Payment And Other Adjustments
RestructuringReservePaymentAndOtherAdjustments
9300000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
5300000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
6300000 usd
us-gaap Restructuring Charges
RestructuringCharges
4200000 usd
ftre Restructuring Reserve Payment And Other Adjustments
RestructuringReservePaymentAndOtherAdjustments
4900000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
5600000 usd
CY2024Q2 ftre Restructuring Reserve Expected Payout Period
RestructuringReserveExpectedPayoutPeriod
P12M
CY2023Q2 ftre Common Stock Separation Conversion Ratio
CommonStockSeparationConversionRatio
1
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88800000 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-99300000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89400000 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.11
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
25000000.0 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88800000 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.28
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-99300000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89400000 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.11
CY2023Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
25000000.0 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88800000 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.28
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-179100000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89300000 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.01
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
33000000.0 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88800000 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.37
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-179100000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89300000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.01
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
33000000.0 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88800000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.37
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-39100000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89400000 shares
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.44
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5800000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88800000 shares
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.07
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-39100000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89400000 shares
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.44
CY2023Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
5800000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88800000 shares
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-60300000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89300000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.68
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
10300000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88800000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.12
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-60300000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89300000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.68
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
10300000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88800000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.12
CY2023Q4 us-gaap Goodwill
Goodwill
1739400000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1707400000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-13700000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
27900000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
1725700000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
1735300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1174400000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
482500000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
691900000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1183700000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
455600000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
728100000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30400000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30400000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
30400000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
58100000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
57300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
57300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
49600000 usd
CY2024Q2 ftre Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
439200000 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1640000000 usd
CY2024Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
450000000.0 usd
CY2024Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0 usd
CY2023Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
4600000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
26100000 usd
CY2024Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
18200000 usd
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
28100000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1123800000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1565900000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
12200000 usd
CY2024Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
12200000 usd
CY2024Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0 usd
CY2024Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
-1100000 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
12500000 usd
CY2024Q2 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
400000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
265000000.0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000.0 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
400000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
500000 usd
CY2024Q2 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
400000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
100000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
19100000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.121
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.317
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10700000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.090
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.284
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 usd
CY2024Q2 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
800000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.52
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
800000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.52
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y4M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10900000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
800000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.52
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
ftre Share Based Compensation Arrangement By Share Based Payment Award Cliff Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod
P3Y
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15400000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8800000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28900000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15100000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2300000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1600000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4300000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2700000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
102000000.0 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
98600000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
194000000.0 usd
us-gaap Interest Paid Net
InterestPaidNet
66800000 usd
us-gaap Interest Paid Net
InterestPaidNet
500000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
52200000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16700000 usd
ftre Noncash Investing And Financing Activities Change In Accrued Property Plant And Equipment
NoncashInvestingAndFinancingActivitiesChangeInAccruedPropertyPlantAndEquipment
-500000 usd
ftre Noncash Investing And Financing Activities Change In Accrued Property Plant And Equipment
NoncashInvestingAndFinancingActivitiesChangeInAccruedPropertyPlantAndEquipment
-200000 usd
ftre Transfer To From Parent Change In Right Of Use Lease Asset
TransferToFromParentChangeInRightOfUseLeaseAsset
0 usd
ftre Transfer To From Parent Change In Right Of Use Lease Asset
TransferToFromParentChangeInRightOfUseLeaseAsset
13900000 usd
ftre Transfer To From Parent Change In Property Plant And Equipment Net
TransferToFromParentChangeInPropertyPlantAndEquipmentNet
0 usd
ftre Transfer To From Parent Change In Property Plant And Equipment Net
TransferToFromParentChangeInPropertyPlantAndEquipmentNet
-27700000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108600000 usd
CY2023Q4 ftre Accounts Receivable And Contract With Customer Asset After Allowance For Credit Loss Current
AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent
988500000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
84600000 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
69100000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1250800000 usd
CY2023Q4 ftre Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
172600000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1739400000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
728100000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3200000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69700000 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
368800000 usd
CY2023Q4 us-gaap Assets
Assets
4332600000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
132900000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
335500000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
214200000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
26100000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17200000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
52500000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
778400000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1565900000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62800000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
147700000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32100000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
31600000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2618500000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 ftre Net Parent Investment
NetParentInvestment
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1998000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68500000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-215500000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1714100000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4332600000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
725100000 usd
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
568700000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97800000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23400000 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
3600000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
693500000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
31600000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-700000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5200000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
500000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36600000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11600000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
25000000.0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.28
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.07
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.28
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.07
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1419000000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1110200000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
214600000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
44300000 usd
us-gaap Restructuring Costs
RestructuringCosts
4200000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1373300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
45700000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-600000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000.0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13100000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
33000000.0 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.37
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.37
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
30800000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
29900000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
-2100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
32000000.0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
32000000.0 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
62800000 usd
us-gaap Net Income Loss
NetIncomeLoss
43300000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
49000000.0 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
-2100000 usd
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
51100000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
51100000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
94400000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3340000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12500000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
19100000 usd
CY2023Q1 ftre Net Transfers From To Parent Excluding Special Payment
NetTransfersFromToParentExcludingSpecialPayment
31200000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3402800000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
30800000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
32000000.0 usd
CY2023Q2 ftre Net Transfers To Parent Special Payment
NetTransfersToParentSpecialPayment
1595000000 usd
CY2023Q2 ftre Net Transfers From To Parent Excluding Special Payment
NetTransfersFromToParentExcludingSpecialPayment
-122900000 usd
CY2023Q2 ftre Adjustments To Additional Paid In Capital Former Parent Investment Reclassification
AdjustmentsToAdditionalPaidInCapitalFormerParentInvestmentReclassification
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1747800000 usd
us-gaap Net Income Loss
NetIncomeLoss
43300000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16100000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14300000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4500000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6500000 usd
ftre Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
-11400000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17200000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19900000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5500000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
15200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
148100000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
25800000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
300000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25500000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1061400000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
570000000.0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
26400000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
ftre Special Payment To Former Parent
SpecialPaymentToFormerParent
1595000000 usd
ftre Proceeds From Payments To Former Parent Company
ProceedsFromPaymentsToFormerParentCompany
-135400000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-125400000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1300000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110400000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108900000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
12200000 usd
CY2024Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
12200000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001965040-24-000054-index-headers.html Edgar Link pending
0001965040-24-000054-index.html Edgar Link pending
0001965040-24-000054.txt Edgar Link pending
0001965040-24-000054-xbrl.zip Edgar Link pending
exhibit101-2024securitizat.htm Edgar Link pending
exhibit102-2024securitizat.htm Edgar Link pending
exhibit103-gscreditagree.htm Edgar Link pending
exhibit103-gscreditagree001.jpg Edgar Link pending
exhibit103-gscreditagree002.jpg Edgar Link pending
exhibit103-gscreditagree003.jpg Edgar Link pending
exhibit103-gscreditagree004.jpg Edgar Link pending
exhibit103-gscreditagree005.jpg Edgar Link pending
exhibit103-gscreditagree006.jpg Edgar Link pending
exhibit103-gscreditagree007.jpg Edgar Link pending
exhibit103-gscreditagree008.jpg Edgar Link pending
exhibit103-gscreditagree009.jpg Edgar Link pending
exhibit103-gscreditagree010.jpg Edgar Link pending
exhibit103-gscreditagree011.jpg Edgar Link pending
exhibit103-gscreditagree012.jpg Edgar Link pending
exhibit103-gscreditagree013.jpg Edgar Link pending
exhibit103-gscreditagree014.jpg Edgar Link pending
exhibit103-gscreditagree015.jpg Edgar Link pending
exhibit103-gscreditagree016.jpg Edgar Link pending
exhibit103-gscreditagree017.jpg Edgar Link pending
exhibit103-gscreditagree018.jpg Edgar Link pending
exhibit103-gscreditagree019.jpg Edgar Link pending
exhibit103-gscreditagree020.jpg Edgar Link pending
exhibit103-gscreditagree021.jpg Edgar Link pending
exhibit103-gscreditagree022.jpg Edgar Link pending
exhibit103-gscreditagree023.jpg Edgar Link pending
exhibit103-gscreditagree024.jpg Edgar Link pending
exhibit103-gscreditagree025.jpg Edgar Link pending
exhibit103-gscreditagree026.jpg Edgar Link pending
exhibit103-gscreditagree027.jpg Edgar Link pending
exhibit103-gscreditagree028.jpg Edgar Link pending
exhibit103-gscreditagree029.jpg Edgar Link pending
exhibit103-gscreditagree030.jpg Edgar Link pending
exhibit103-gscreditagree031.jpg Edgar Link pending
exhibit103-gscreditagree032.jpg Edgar Link pending
exhibit103-gscreditagree033.jpg Edgar Link pending
exhibit103-gscreditagree034.jpg Edgar Link pending
exhibit103-gscreditagree035.jpg Edgar Link pending
exhibit103-gscreditagree036.jpg Edgar Link pending
exhibit103-gscreditagree037.jpg Edgar Link pending
exhibit103-gscreditagree038.jpg Edgar Link pending
exhibit103-gscreditagree039.jpg Edgar Link pending
exhibit103-gscreditagree040.jpg Edgar Link pending
exhibit103-gscreditagree041.jpg Edgar Link pending
exhibit103-gscreditagree042.jpg Edgar Link pending
exhibit103-gscreditagree043.jpg Edgar Link pending
exhibit103-gscreditagree044.jpg Edgar Link pending
exhibit103-gscreditagree045.jpg Edgar Link pending
exhibit103-gscreditagree046.jpg Edgar Link pending
exhibit103-gscreditagree047.jpg Edgar Link pending
exhibit103-gscreditagree048.jpg Edgar Link pending
exhibit103-gscreditagree049.jpg Edgar Link pending
exhibit103-gscreditagree050.jpg Edgar Link pending
exhibit103-gscreditagree051.jpg Edgar Link pending
exhibit103-gscreditagree052.jpg Edgar Link pending
exhibit103-gscreditagree053.jpg Edgar Link pending
exhibit103-gscreditagree054.jpg Edgar Link pending
exhibit103-gscreditagree055.jpg Edgar Link pending
exhibit103-gscreditagree056.jpg Edgar Link pending
exhibit103-gscreditagree057.jpg Edgar Link pending
exhibit103-gscreditagree058.jpg Edgar Link pending
exhibit103-gscreditagree059.jpg Edgar Link pending
exhibit103-gscreditagree060.jpg Edgar Link pending
exhibit103-gscreditagree061.jpg Edgar Link pending
exhibit103-gscreditagree062.jpg Edgar Link pending
exhibit103-gscreditagree063.jpg Edgar Link pending
exhibit103-gscreditagree064.jpg Edgar Link pending
exhibit103-gscreditagree065.jpg Edgar Link pending
exhibit103-gscreditagree066.jpg Edgar Link pending
exhibit103-gscreditagree067.jpg Edgar Link pending
exhibit103-gscreditagree068.jpg Edgar Link pending
exhibit103-gscreditagree069.jpg Edgar Link pending
exhibit103-gscreditagree070.jpg Edgar Link pending
exhibit103-gscreditagree071.jpg Edgar Link pending
exhibit103-gscreditagree072.jpg Edgar Link pending
exhibit103-gscreditagree073.jpg Edgar Link pending
exhibit103-gscreditagree074.jpg Edgar Link pending
exhibit103-gscreditagree075.jpg Edgar Link pending
exhibit103-gscreditagree076.jpg Edgar Link pending
exhibit103-gscreditagree077.jpg Edgar Link pending
exhibit103-gscreditagree078.jpg Edgar Link pending
exhibit103-gscreditagree079.jpg Edgar Link pending
exhibit103-gscreditagree080.jpg Edgar Link pending
exhibit103-gscreditagree081.jpg Edgar Link pending
exhibit103-gscreditagree082.jpg Edgar Link pending
exhibit103-gscreditagree083.jpg Edgar Link pending
exhibit103-gscreditagree084.jpg Edgar Link pending
exhibit103-gscreditagree085.jpg Edgar Link pending
exhibit103-gscreditagree086.jpg Edgar Link pending
exhibit103-gscreditagree087.jpg Edgar Link pending
exhibit103-gscreditagree088.jpg Edgar Link pending
exhibit103-gscreditagree089.jpg Edgar Link pending
exhibit103-gscreditagree090.jpg Edgar Link pending
exhibit103-gscreditagree091.jpg Edgar Link pending
exhibit103-gscreditagree092.jpg Edgar Link pending
exhibit103-gscreditagree093.jpg Edgar Link pending
exhibit103-gscreditagree094.jpg Edgar Link pending
exhibit103-gscreditagree095.jpg Edgar Link pending
exhibit103-gscreditagree096.jpg Edgar Link pending
exhibit103-gscreditagree097.jpg Edgar Link pending
exhibit103-gscreditagree098.jpg Edgar Link pending
exhibit103-gscreditagree099.jpg Edgar Link pending
exhibit103-gscreditagree100.jpg Edgar Link pending
exhibit103-gscreditagree101.jpg Edgar Link pending
exhibit103-gscreditagree102.jpg Edgar Link pending
exhibit103-gscreditagree103.jpg Edgar Link pending
exhibit103-gscreditagree104.jpg Edgar Link pending
exhibit103-gscreditagree105.jpg Edgar Link pending
exhibit103-gscreditagree106.jpg Edgar Link pending
exhibit103-gscreditagree107.jpg Edgar Link pending
exhibit103-gscreditagree108.jpg Edgar Link pending
exhibit103-gscreditagree109.jpg Edgar Link pending
exhibit103-gscreditagree110.jpg Edgar Link pending
exhibit103-gscreditagree111.jpg Edgar Link pending
exhibit103-gscreditagree112.jpg Edgar Link pending
exhibit103-gscreditagree113.jpg Edgar Link pending
exhibit103-gscreditagree114.jpg Edgar Link pending
exhibit103-gscreditagree115.jpg Edgar Link pending
exhibit103-gscreditagree116.jpg Edgar Link pending
exhibit103-gscreditagree117.jpg Edgar Link pending
exhibit103-gscreditagree118.jpg Edgar Link pending
exhibit103-gscreditagree119.jpg Edgar Link pending
exhibit103-gscreditagree120.jpg Edgar Link pending
exhibit103-gscreditagree121.jpg Edgar Link pending
exhibit103-gscreditagree122.jpg Edgar Link pending
exhibit103-gscreditagree123.jpg Edgar Link pending
exhibit103-gscreditagree124.jpg Edgar Link pending
exhibit103-gscreditagree125.jpg Edgar Link pending
exhibit103-gscreditagree126.jpg Edgar Link pending
exhibit103-gscreditagree127.jpg Edgar Link pending
exhibit103-gscreditagree128.jpg Edgar Link pending
exhibit103-gscreditagree129.jpg Edgar Link pending
exhibit103-gscreditagree130.jpg Edgar Link pending
exhibit103-gscreditagree131.jpg Edgar Link pending
exhibit103-gscreditagree132.jpg Edgar Link pending
exhibit103-gscreditagree133.jpg Edgar Link pending
exhibit103-gscreditagree134.jpg Edgar Link pending
exhibit103-gscreditagree135.jpg Edgar Link pending
exhibit103-gscreditagree136.jpg Edgar Link pending
exhibit103-gscreditagree137.jpg Edgar Link pending
exhibit103-gscreditagree138.jpg Edgar Link pending
exhibit103-gscreditagree139.jpg Edgar Link pending
exhibit103-gscreditagree140.jpg Edgar Link pending
exhibit103-gscreditagree141.jpg Edgar Link pending
exhibit103-gscreditagree142.jpg Edgar Link pending
exhibit103-gscreditagree143.jpg Edgar Link pending
exhibit103-gscreditagree144.jpg Edgar Link pending
exhibit103-gscreditagree145.jpg Edgar Link pending
exhibit103-gscreditagree146.jpg Edgar Link pending
exhibit103-gscreditagree147.jpg Edgar Link pending
exhibit103-gscreditagree148.jpg Edgar Link pending
exhibit103-gscreditagree149.jpg Edgar Link pending
exhibit103-gscreditagree150.jpg Edgar Link pending
exhibit103-gscreditagree151.jpg Edgar Link pending
exhibit103-gscreditagree152.jpg Edgar Link pending
exhibit103-gscreditagree153.jpg Edgar Link pending
exhibit103-gscreditagree154.jpg Edgar Link pending
exhibit103-gscreditagree155.jpg Edgar Link pending
exhibit103-gscreditagree156.jpg Edgar Link pending
exhibit103-gscreditagree157.jpg Edgar Link pending
exhibit103-gscreditagree158.jpg Edgar Link pending
exhibit103-gscreditagree159.jpg Edgar Link pending
exhibit103-gscreditagree160.jpg Edgar Link pending
exhibit103-gscreditagree161.jpg Edgar Link pending
exhibit103-gscreditagree162.jpg Edgar Link pending
exhibit103-gscreditagree163.jpg Edgar Link pending
exhibit103-gscreditagree164.jpg Edgar Link pending
exhibit103-gscreditagree165.jpg Edgar Link pending
exhibit103-gscreditagree166.jpg Edgar Link pending
exhibit103-gscreditagree167.jpg Edgar Link pending
exhibit103-gscreditagree168.jpg Edgar Link pending
exhibit103-gscreditagree169.jpg Edgar Link pending
exhibit103-gscreditagree170.jpg Edgar Link pending
exhibit103-gscreditagree171.jpg Edgar Link pending
exhibit103-gscreditagree172.jpg Edgar Link pending
exhibit103-gscreditagree173.jpg Edgar Link pending
exhibit103-gscreditagree174.jpg Edgar Link pending
exhibit103-gscreditagree175.jpg Edgar Link pending
exhibit103-gscreditagree176.jpg Edgar Link pending
exhibit103-gscreditagree177.jpg Edgar Link pending
exhibit103-gscreditagree178.jpg Edgar Link pending
exhibit103-gscreditagree179.jpg Edgar Link pending
exhibit103-gscreditagree180.jpg Edgar Link pending
exhibit103-gscreditagree181.jpg Edgar Link pending
exhibit103-gscreditagree182.jpg Edgar Link pending
exhibit103-gscreditagree183.jpg Edgar Link pending
exhibit103-gscreditagree184.jpg Edgar Link pending
exhibit103-gscreditagree185.jpg Edgar Link pending
exhibit103-gscreditagree186.jpg Edgar Link pending
exhibit103-gscreditagree187.jpg Edgar Link pending
exhibit103-gscreditagree188.jpg Edgar Link pending
exhibit103-gscreditagree189.jpg Edgar Link pending
exhibit103-gscreditagree190.jpg Edgar Link pending
exhibit103-gscreditagree191.jpg Edgar Link pending
exhibit103-gscreditagree192.jpg Edgar Link pending
exhibit103-gscreditagree193.jpg Edgar Link pending
exhibit103-gscreditagree194.jpg Edgar Link pending
exhibit103-gscreditagree195.jpg Edgar Link pending
exhibit103-gscreditagree196.jpg Edgar Link pending
exhibit103-gscreditagree197.jpg Edgar Link pending
exhibit103-gscreditagree198.jpg Edgar Link pending
exhibit103-gscreditagree199.jpg Edgar Link pending
exhibit103-gscreditagree200.jpg Edgar Link pending
exhibit103-gscreditagree201.jpg Edgar Link pending
exhibit103-gscreditagree202.jpg Edgar Link pending
exhibit103-gscreditagree203.jpg Edgar Link pending
exhibit103-gscreditagree204.jpg Edgar Link pending
exhibit103-gscreditagree205.jpg Edgar Link pending
exhibit103-gscreditagree206.jpg Edgar Link pending
exhibit103-gscreditagree207.jpg Edgar Link pending
exhibit103-gscreditagree208.jpg Edgar Link pending
exhibit103-gscreditagree209.jpg Edgar Link pending
exhibit103-gscreditagree210.jpg Edgar Link pending
exhibit103-gscreditagree211.jpg Edgar Link pending
exhibit103-gscreditagree212.jpg Edgar Link pending
exhibit103-gscreditagree213.jpg Edgar Link pending
exhibit103-gscreditagree214.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ftre-20240630.htm Edgar Link pending
ftre-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
q224exhibit-311.htm Edgar Link pending
q224exhibit-312.htm Edgar Link pending
q224exhibit-322.htm Edgar Link pending
q224exhibit321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ftre-20240630_cal.xml Edgar Link unprocessable
ftre-20240630_def.xml Edgar Link unprocessable
ftre-20240630_lab.xml Edgar Link unprocessable
ftre-20240630_pre.xml Edgar Link unprocessable
ftre-20240630_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending